A Diagnostics & Imaging Week
Steven Mrha, COO for Non-Invasive Monitoring Systems (NIMS; North Bay Village, Florida), reported that the U.S. Patent Office has issued it Patent NO. 7,111,346, titled, "Reciprocating movement platform for the external addition of pulses of the fluid channels of a subject."
Mrha said, "This fourth patent, the first issued as U.S. patent 6,155,976 in 2000, encompasses 83 claims that further protect the value of the company's flagship products [Exer-Rest AT and Exer-Rest] for therapeutic and diagnostic applications that have already been published in peer-reviewed research studies, as well as for future products and applications."
Marvin Sackner, CEO/chairman of the company, and the technology's inventor, said, "This patent describes the means to achieve the horizontal movements of the acceleration therapeutics platform technology and adds new applications for its use. These include prevention and treatment of athletic injuries, exercise-induced asthma, post-exercise muscular cramping, as well as reduction and/or prevention of susceptibility of athletes to viral and bacterial infections.
"The patent claims include among others the means to treat and/or prevent cognitive deficits, learning deficits and/or behavioral abnormalities in early cognitive impairment."
The company said it expects to file an FDA application for approval by the fourth quarter of this year.